Drug    DrugBank | All Description Patterns💬 Info on mouse-over

No.	Drug (Description in trials)	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	Disease ID
1	Naloxone	Naloxone	[2] D01340, D08249 💬	[3] OPRD1, OPRK1, OPRM1 💬	[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	[2]  6 , 226 💬
2	Naloxone hydrochloride	Naloxone	[2] D01340, D08249 💬	[3] OPRD1, OPRK1, OPRM1 💬	[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	[1] 226 💬
3	Naloxone hydrochloride dihydrate	Naloxone	[2] D01340, D08249 💬	[3] OPRD1, OPRK1, OPRM1 💬	[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	[1]  6  💬
4	Oxycodone naloxone prolonged release tablets	Naloxone	[5] D01340, D03783, D05312, D05462, D08249 💬	[3] OPRD1, OPRK1, OPRM1 💬	[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	[1] 226 💬
5	Oxycodone/naloxone prolonged release t	Naloxone	[5] D01340, D03783, D05312, D05462, D08249 💬	[3] OPRD1, OPRK1, OPRM1 💬	[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	[1] 226 💬
6	Oxycodone/naloxone prolonged release tablets	Naloxone	[5] D01340, D03783, D05312, D05462, D08249 💬	[3] OPRD1, OPRK1, OPRM1 💬	[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	[1]  6  💬
7	Oxycodone/naloxone prolonged release tablets 10 mg /5 mg	Naloxone	[5] D01340, D03783, D05312, D05462, D08249 💬	[3] OPRD1, OPRK1, OPRM1 💬	[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	[1]  6  💬
8	Oxycodone/naloxone prolonged release tablets 10/5 mg	Naloxone	[5] D01340, D03783, D05312, D05462, D08249 💬	[3] OPRD1, OPRK1, OPRM1 💬	[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	[1] 226 💬
9	Oxycodone/naloxone prolonged release tablets 20 mg /10 mg	Naloxone	[5] D01340, D03783, D05312, D05462, D08249 💬	[3] OPRD1, OPRK1, OPRM1 💬	[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	[1]  6  💬
10	Oxycodone/naloxone prolonged release tablets 20/10 mg	Naloxone	[5] D01340, D03783, D05312, D05462, D08249 💬	[3] OPRD1, OPRK1, OPRM1 💬	[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	[1] 226 💬
11	Oxycodone/naloxone prolonged release tablets 5 mg /2.5 mg	Naloxone	[5] D01340, D03783, D05312, D05462, D08249 💬	[3] OPRD1, OPRK1, OPRM1 💬	[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	[1]  6  💬
12	Oxycodone/naloxone prolonged release tablets 5/2.5 mg	Naloxone	[5] D01340, D03783, D05312, D05462, D08249 💬	[3] OPRD1, OPRK1, OPRM1 💬	[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	[1] 226 💬